熱門資訊> 正文
Bright Green与PharmAGRI Capital Partners合并，任命新首席执行官
2025-09-16 14:57
- Bright Green (OTC:BGXXQ) announced merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty.
- Effective immediately, Lynn Stockwell has been appointed CEO and Chairwoman of PharmAGRI.
- The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico.
- The company intends to complete its IPO before year-end 2025, positioning PharmAGRI for full market access.
More on Bright Green
- Financial information for Bright Green
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
